Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by longterm56on Mar 08, 2020 7:50pm
229 Views
Post# 30781373

Does Due Diligence Work??

Does Due Diligence Work??I find it quite amusing that the 8-10 "catalysts" we were all waiting for last year came and went with minimal impact to the stock. But the one thing that actually moved the stock price a bit was totally unexpected (except for SPCEO ... who hinted at it a few times). So I'm wondering ... does all the due diligence and research people on this board contribute make any difference at all??? Also, don't be so quick to praise this new CEO. Of course he has amazing reviews from the board president and others ... but what are they supposed to say ... "Yea, we had to settle for this guy because our first six choices didn't want the job."? Get real, all, we don't know anything about what this guy can do until he demonstrates it to us. Optimistic ... but cautious ... -LT
Bullboard Posts